Table of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Chapter 6. Global Inflammatory Bowel Disease Treatment Market, by Drug Class
6.1 Introduction
6.2 TNF Inhibitors
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
6.3 Aminosalicylates
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
6.4 Immunomodulators
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
6.5 Corticosteroids
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
Chapter 7. Global Inflammatory Bowel Disease Treatment Market, by Disease Indication
7.1 Introduction
7.2 Ulcerative Colitis
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
7.3 Crohn’s Disease
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
Chapter 8. Global Inflammatory Bowel Disease Treatment Market, by Distribution Channel
8.1 Introduction
8.2 Hospital Pharmacy
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
8.3 Retail Pharmacy
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
8.4 Online Pharmacy
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
Chapter 9. Global Inflammatory Bowel Disease Treatment Market, by End-User
9.1 Introduction
9.2 Hospitals & Clinics
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
9.3 Others
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
Chapter 10. Global Inflammatory Bowel Disease Treatment Market, by Region
10.1 Introduction
10.2 Americas
10.2.1 North America
10.2.1.1 US
10.2.1.2 Canada
10.2.2 South America
10.3 Europe
10.3.1 Western Europe
10.3.1.1 Germany
10.3.1.2 France
10.3.1.3 Italy
10.3.1.4 Spain
10.3.1.5 UK
10.3.1.6 Rest of Western Europe
10.3.2 Eastern Europe
10.4 Asia-Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 South Korea
10.4.6 Rest of Asia-Pacific
10.5 Middle East & Africa
10.5.1 Middle East
10.5.2 Africa
Chapter 11. Company Landscape
11.1 Introduction
11.2 Market Share Analysis
11.3 Key Development & Strategies
Chapter 12. Company Profiles
12.1 Abbott Laboratories
12.1.1 Company Overview
12.1.2 Product Overview
12.1.3 Financials
12.1.4 SWOT Analysis
12.2 Valeant Pharmaceuticals International
12.2.1 Company Overview
12.2.2 Product Overview
12.2.3 Financial Overview
12.2.4 Key Developments
12.2.5 SWOT Analysis
12.3 Novartis AG
12.3.1 Company Overview
12.3.2 Product Overview
12.3.3 Financial Overview
12.3.4 Key Development
12.3.5 SWOT Analysis
12.4 Janssen Biotech, Inc.
12.4.1 Company Overview
12.4.2 Product/Business Segment Overview
12.4.3 Financial Overview
12.4.4 Key Development
12.4.5 SWOT Analysis
12.5 Alkem Laboratories Limited
12.5.1 Company Overview
12.5.2 Product Overview
12.5.3 Financial overview
12.5.4 Key Developments
12.6 AbbVie, Inc.
12.6.1 Company Overview
12.6.2 Product Overview
12.6.3 Financial Overview
12.6.4 Key Developments
12.7 UCB Inc
12.7.1 Overview
12.7.2 Product Overview
12.7.3 Financials
12.7.4 Key Developments
12.7.5 SWOT Analysis
12.8 Takeda Pharmaceutical Company Limited
12.8.1 Overview
12.8.2 Product Overview
12.8.3 Financials
12.8.4 Key Developments
12.8.5 SWOT Analysis
12.9 Biogen Inc.
12.9.1 Overview
12.9.2 Product Overview
12.9.3 Financials
12.9.4 Key Developments
12.9.5 SWOT Analysis
12.10 Pfizer Inc.
12.10.1 Overview
12.10.2 Product Overview
12.10.3 Financials
12.10.4 Key Developments
12.10.5 SWOT Analysis
12.11 Allergan plc.
12.11.1 Overview
12.11.2 Product Overview
12.11.3 Financials
12.11.4 Key Developments
12.11.5 SWOT Analysis
12.12 Others
Chapter 13 MRFR Conclusion
13.1 Key Findings
13.1.1 From the CEO’s Viewpoint
13.1.2 Unmet Needs of the Market
13.2 Key Companies to Watch
13.3 Predictions for the Inflammatory Bowel Disease Treatment Industry
Chapter 14. Appendix
LIST OF TABLES
Table 1 Global Inflammatory Bowel Disease Treatment Market Synopsis, 2020–2027
Table 2 Global Inflammatory Bowel Disease Treatment Market Estimates and Forecast, 2020–2027 (USD Million)
Table 3 Global Inflammatory Bowel Disease Treatment Market, by Region, 2020–2027 (USD Million)
Table 4 Global Inflammatory Bowel Disease Treatment Market, by Disease Indication, 2020–2027 (USD Million)
Table 5 Global Inflammatory Bowel Disease Treatment Market, by Drug Class, 2020–2027 (USD Million)
Table 6 Global Inflammatory Bowel Disease Treatment Market, by Distribution Channel, 2020–2027 (USD Million)
Table 7 Global Inflammatory Bowel Disease Treatment Market, by End-User, 2020–2027 (USD Million)
Table 8 North America: Inflammatory Bowel Disease Treatment Market, by Disease Indication, 2020–2027 (USD
Million)
Table 9 North America: Inflammatory Bowel Disease Treatment Market, by Drug Class, 2020–2027 (USD
Million)
Table 10 North America: Inflammatory Bowel Disease Treatment Market, by Distribution Channel, 2020–2027 (USD Million)
Table 11 North America: Inflammatory Bowel Disease Treatment Market, by End-User, 2020–2027 (USD Million)
Table 12 US: Inflammatory Bowel Disease Treatment Market, by Disease Indication, 2020–2027 (USD Milion)
Table 13 US: Inflammatory Bowel Disease Treatment Market, by Drug Class, 2020–2027 (USD Million)
Table 14 US: Inflammatory Bowel Disease Treatment Market, by Distribution Channel, 2020–2027 (USD Million)
Table 15 US: Inflammatory Bowel Disease Treatment Market, by End-User, 2020–2027 (USD Million)
Table 16 Canada: Inflammatory Bowel Disease Treatment Market, by Disease Indication, 2020–2027 (USD Million)
Table 17 Canada: Inflammatory Bowel Disease Treatment Market, by Drug Class, 2020–2027 (USD Million)
Table 18 Canada: Inflammatory Bowel Disease Treatment Market, by Distribution Channel, 2020–2027 (USD Million)
Table 19 Canada: Inflammatory Bowel Disease Treatment Market, by End-User, 2020–2027 (USD Million)
Table 20 South America: Inflammatory Bowel Disease Treatment Market, by Disease Indication, 2020–2027 (USD Million)
Table 21 South America: Inflammatory Bowel Disease Treatment Market, by Drug Class, 2020–2027 (USD Million)
Table 22 South America: Inflammatory Bowel Disease Treatment Market, by Distribution Channel, 2020–2027 (USD Million)
Table 23 South America: Inflammatory Bowel Disease Treatment Market, by End-User, 2020–2027 (USD Million)
Table 24 Europe: Inflammatory Bowel Disease Treatment Market, by Disease Indication, 2020–2027 (USD Million)
Table 25 Europe: Inflammatory Bowel Disease Treatment Market, by Drug Class, 2020–2027 (USD Million)
Table 25 Europe: Inflammatory Bowel Disease Treatment Market, by Distribution Channel, 2020–2027 (USD Million)
Table 26 Europe: Inflammatory Bowel Disease Treatment Market, by End-User, 2020–2027 (USD Million)
Table 27 Western Europe: Inflammatory Bowel Disease Treatment Market, by Disease Indication, 2020–2027 (USD Million)
Table 28 Western Europe: Inflammatory Bowel Disease Treatment Market, by Drug Class, 2020–2027 (USD Million)
Table 29 Western Europe: Inflammatory Bowel Disease Treatment Market, by Distribution Channel, 2020–2027 (USD Million)
Table 30 Western Europe: Inflammatory Bowel Disease Treatment Market, by End-User, 2020–2027 (USD Million)
Table 31 Eastern Europe: Inflammatory Bowel Disease Treatment Market, by Disease Indication, 2020–2027 (USD Million)
Table 32 Eastern Europe: Inflammatory Bowel Disease Treatment Market, by Drug Class, 2020–2027 (USD Million)
Table 33 Eastern Europe: Inflammatory Bowel Disease Treatment Market, by Distribution Channel, 2020–2027 (USD Million)
Table 34 Eastern Europe: Inflammatory Bowel Disease Treatment Market, by End-User, 2020–2027 (USD Million)
Table 35 Asia-Pacific: Inflammatory Bowel Disease Treatment Market, by Disease Indication, 2020–2027 (USD Million)
Table 36 Asia-Pacific: Inflammatory Bowel Disease Treatment Market, by Drug Class, 2020–2027 (USD Million)
Table 37 Asia-Pacific: Inflammatory Bowel Disease Treatment Market, by Distribution Channel, 2020–2027 (USD Million)
Table 38 Asia-Pacific: Inflammatory Bowel Disease Treatment Market, by End-User, 2020–2027 (USD Million)
Table 39 Middle East & Africa: Inflammatory Bowel Disease Treatment Market, by Disease Indication, 2020–2027 (USD Million)
Table 40 Middle East & Africa: Inflammatory Bowel Disease Treatment Market, by Drug Class, 2020–2027 (USD Million)
Table 41 Middle East & Africa: Inflammatory Bowel Disease Treatment Market, by Distribution Channel, 2020–2027 (USD Million)
Table 42 Middle East & Africa: Inflammatory Bowel Disease Treatment Market, by End-User, 2020–2027 (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Global Inflammatory Bowel Disease Treatment Market
Figure 3 Segmentation Market Dynamics for Inflammatory Bowel Disease Treatment Market
Figure 4 Global Inflammatory Bowel Disease Treatment Market Share, by Disease Indication, 2020
Figure 5 Global Inflammatory Bowel Disease Treatment Market Share, by Drug Class, 2020
Figure 6 Global Inflammatory Bowel Disease Treatment Market Share, by Distribution Channel, 2020
Figure 7 Global Inflammatory Bowel Disease Treatment Market Share, by End-User, 2020
Figure 8 Global Inflammatory Bowel Disease Treatment Market Share, by Region, 2020
Figure 9 North America: Inflammatory Bowel Disease Treatment Market Share, by Country, 2020
Figure 10 Europe: Inflammatory Bowel Disease Treatment Market Share, by Country, 2020
Figure 11 Asia-Pacific: Inflammatory Bowel Disease Treatment Market Share, by Country, 2020
Figure 12 Middle East & Africa: Inflammatory Bowel Disease Treatment Market Share, by Country, 2013
Figure 13 Global Inflammatory Bowel Disease Treatment Market: Company Share Analysis, 2020 (%)
Figure 14 Abbott Laboratories: Key Financials
Figure 15 Abbott Laboratories: Segmental Revenue
Figure 16 Abbott Laboratories: Geographical Revenue
Figure 17 Thermo Fisher Scientific. Key Financials
Figure 18 Novartis AG: Segmental Revenue
Figure 19 Novartis AG: Geographical Revenue
Figure 20 Takeda Pharmaceutical Company Limited: Key Financials
Figure 21 Takeda Pharmaceutical Company Limited: Segmental Revenue
Figure 22 Takeda Pharmaceutical Company Limited: Geographical Revenue
Figure 23 Pfizer Inc.: Key Financials
Figure 24 Pfizer Inc.: Segmental Revenue
Figure 25 Pfizer Inc.: Geographical Revenue
Figure 26 Biogen Inc.: Key Financials
Figure 27 Biogen Inc.: Segmental Revenue
Figure 28 Biogen Inc.: Geographical Revenue
Figure 29 Valeant Pharmaceuticals International: Key Financials
Figure 30 Valeant Pharmaceuticals International: Segmental Revenue
Figure 31 Valeant Pharmaceuticals International: Geographical Revenue
